Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the current coronavirus disease 2019 (COVID-19) pandemic that has led to a global economic disruption and collapse. With several ongoing eﬀorts to develop vaccines and treatments for COVID-19, understanding the molecular interaction between the coronavirus, host cells, and the immune system is critical for eﬀective therapeutic interventions. Greater insight into these mechanisms will require the contribution and combination of multiple scientific disciplines including the techniques and strategies that have been successfully deployed by chemical biology to tease apart complex biological pathways. We highlight in this review well-established strategies and methods to study coronavirus–host biophysical interactions and discuss the impact chemical biology will have on understanding these interactions at the molecular level. 2 (ACE2) on alveolar cells, and establishment of upper respiratory tract infection via nose, eyes and mouth, the viral lifecycle proceeds with the fusion of viral envelope with cell membrane and subsequent release of viral RNA into the cell. The RNA is then translated to produce viral pre-proteins that are processed by its own proteases to release over two dozen eﬀector proteins which eventually participate in viral replication, hijacking of host pathways, and assembly of virions followed by release. or sub-genomic RNAs) are recognized by pattern recognition receptors such as Toll-like receptors (TLRs), retinoic- acid-inducible protein I (RIG-I), RIG-I like receptor, and melanoma differentiation-associated protein 5 (MDA-5) that recruit adapter mitochondrial antiviral-signaling protein (MAVS) and leads to activation of interferon regulatory factor 3 (IRF3) and NF- k B and the subsequent production of type I Interferons (IFNs) and pro-inflammatory cytokines ( e.g. IL-1 b and IL-6), respectively. Itaconate, an anti-inflammatory metabolite transported by TCA cycle intermediates ( e.g. citrate), results in activation of pathways involved in proinflammatory cytokines. Proinflammatory cytokines activate the mammalian target of rapamycin (mTOR) signaling in addition to the increased energy metabolism through aerobic glycolysis. The increased production of tricarboxylic acid cycle (TCA) intermediates e.g. succinate and citrate activate NF- k B downstream signaling resulting in the production of proin- flammatory cytokines. The antiviral activity of type I IFNs limit viral replication and modulate the innate and adaptive immune responses. They bind to interferon- a / b receptors (IFNARs), which are expressed on a number of different cells including macrophages and activate the JAK/STAT signaling pathway. This signaling leads to the formation of the STAT1/2/IRF9 complex and the induction of a plethora of IFN-stimulated genes (ISGs). Cytokines released by infected cells modulate the adaptive immune response by recruiting and activating immune cells such as macrophages, B-cells, and T-cells to orchestrate the elimination of the virus. However, an unbalanced immune response has been reported to cause hyper-inflammation, a condition termed as ‘cytokine storm’ in cases of severe clinical symptoms of COVID-19. Many, but not all, aspects of this model have been directly verified in the rapidly emerging SARS-CoV-2 experimental literature. characterize possible changes in the hijacked host protein function(s). Both IP-MS and AP-MS

Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‐19 (Review)

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19

JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis

Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection

SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway

Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy

The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections

Redirecting the JAK‐STAT signal blocks the SARS‐CoV‐2 replication

SARS-CoV-2, Inflammatory Apoptosis, and Cytokine Storm Syndrome

Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells

An Update on Innate Immune Responses during SARS-CoV-2 Infection

Basic implications on three pathways associated with SARS-CoV-2

RSC Chemical Biology

Viral and Host Factors Related to the Clinical Outcome of COVID-19

Attenuated Interferon and Proinflammatory Response in SARS-CoV-2–Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

Integrated Interactome and Transcriptome Analysis Reveals Key Host Factors Critical for SARS-CoV-2 Infection.